ATE517093T1 - Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträglichen säureadditionssalzen - Google Patents

Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträglichen säureadditionssalzen

Info

Publication number: ATE517093T1
Authority: AT; Austria
Prior art keywords: ivabradine; producing; pharmaceutically acceptable; acid addition; addition salts
Prior art date: 2009-03-31

Application number

AT10290165T

Other languages

English (en)

Inventor

Jean-Louis Peglion

Aimee Dessinges

Bernard Serkiz

Original Assignee

Servier Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-03-31

Filing date

2010-03-30

Publication date

2011-08-15

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40983371&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE517093(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2010-03-30 Application filed by Servier Lab filed Critical Servier Lab

2011-08-15 Application granted granted Critical

2011-08-15 Publication of ATE517093T1 publication Critical patent/ATE517093T1/de

Links

239000002253 acid Substances 0.000 title 1
ACRHBAYQBXXRTO-OAQYLSRUSA-N ivabradine Chemical compound C1CC2=CC(OC)=C(OC)C=C2CC(=O)N1CCCN(C)C[C@H]1CC2=C1C=C(OC)C(OC)=C2 ACRHBAYQBXXRTO-OAQYLSRUSA-N 0.000 title 1
229960003825 ivabradine Drugs 0.000 title 1
238000004519 manufacturing process Methods 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/16—Benzazepines; Hydrogenated benzazepines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Veterinary Medicine (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Hospice & Palliative Care (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Other In-Based Heterocyclic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Saccharide Compounds (AREA)
Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
Plural Heterocyclic Compounds (AREA)
Peptides Or Proteins (AREA)

AT10290165T 2009-03-31 2010-03-30 Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträglichen säureadditionssalzen ATE517093T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR0901556A FR2943668B1 (fr)	2009-03-31	2009-03-31	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable.

Publications (1)

Publication Number	Publication Date
ATE517093T1 true ATE517093T1 (de)	2011-08-15

Family

ID=40983371

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT10290165T ATE517093T1 (de)	2009-03-31	2010-03-30	Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträglichen säureadditionssalzen

Country Status (34)

Country	Link
US (1)	US8119794B2 (de)
EP (1)	EP2241553B1 (de)
JP (1)	JP5107381B2 (de)
KR (1)	KR101166632B1 (de)
CN (1)	CN101851204B (de)
AR (1)	AR075978A1 (de)
AT (1)	ATE517093T1 (de)
AU (1)	AU2010201035B2 (de)
BR (1)	BRPI1000865A2 (de)
CA (1)	CA2697563C (de)
CL (1)	CL2010000253A1 (de)
CY (1)	CY1111914T1 (de)
DK (1)	DK2241553T3 (de)
EA (1)	EA016353B1 (de)
ES (1)	ES2370150T3 (de)
FR (1)	FR2943668B1 (de)
GE (1)	GEP20125446B (de)
HR (1)	HRP20110683T1 (de)
JO (1)	JO2781B1 (de)
MA (1)	MA31746B1 (de)
ME (1)	ME00986B (de)
MX (1)	MX2010003213A (de)
MY (1)	MY150014A (de)
NZ (1)	NZ584310A (de)
PE (1)	PE20110098A1 (de)
PL (1)	PL2241553T3 (de)
RS (1)	RS51920B (de)
SA (1)	SA110310239B1 (de)
SI (1)	SI2241553T1 (de)
TW (1)	TWI376371B (de)
UA (1)	UA105894C2 (de)
UY (1)	UY32499A (de)
WO (1)	WO2010112705A1 (de)
ZA (1)	ZA201002120B (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PT2471780E (pt) *	2007-05-30	2015-02-24	Ind Swift Lab Ltd	Sais oxalato de ivabradina cristalinos e seus polimorfos
FR2971507B1 (fr) *	2011-02-14	2013-01-18	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2984320B1 (fr) *	2011-12-20	2013-11-29	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2988720B1 (fr) *	2012-03-27	2014-03-14	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
CN103848789B (zh) *	2012-11-29	2016-05-18	江苏恒瑞医药股份有限公司	一种伊伐布雷定的制备方法
EP3101010A1 (de)	2015-06-03	2016-12-07	Urquima S.A.	Neues verfahren zur herstellung von hochreinem ivabradine und dessen salzen
CN113372274B (zh) *	2020-03-10	2023-03-24	鲁南制药集团股份有限公司	一种伊伐布雷定的制备方法
CN113372273B (zh) *	2020-03-10	2023-05-09	鲁南制药集团股份有限公司	一种伊伐布雷定中间体化合物iv

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3119874A1 (de) *	1981-05-19	1982-12-09	Dr. Karl Thomae Gmbh, 7950 Biberach	"benzazepinderivate, ihre herstellung und ihre verwendung als arzneimittel"
FR2681862B1 (fr) *	1991-09-27	1993-11-12	Adir Cie	Nouvelles (benzocycloalkyl)alkylamines, leur procede de preparation, et les compositions pharmaceutiques qui les contiennent.
FR2868777B1 (fr) *	2004-04-13	2006-05-26	Servier Lab	Nouveau procede de synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
FR2870537A1 (fr) *	2004-05-19	2005-11-25	Servier Lab	Nouveau procede de synthese du (1s)-4,5-dimethoxy-1-(methyl aminomethyl-)-benzocyclobutane et de ses sels d'addition, et application a la synthese de l'ivabradine et de ses sels d'addition a un acide pharmaceutiquement acceptable
PT2471780E (pt)	2007-05-30	2015-02-24	Ind Swift Lab Ltd	Sais oxalato de ivabradina cristalinos e seus polimorfos

2009
- 2009-03-31 ME MEP-2010-54A patent/ME00986B/me unknown
- 2009-03-31 FR FR0901556A patent/FR2943668B1/fr not_active Expired - Fee Related
2010
- 2010-03-16 PE PE2010000155A patent/PE20110098A1/es not_active Application Discontinuation
- 2010-03-17 UY UY0001032499A patent/UY32499A/es not_active Application Discontinuation
- 2010-03-17 AU AU2010201035A patent/AU2010201035B2/en not_active Ceased
- 2010-03-17 MY MYPI2010001175A patent/MY150014A/en unknown
- 2010-03-18 MA MA32705A patent/MA31746B1/fr unknown
- 2010-03-22 CL CL2010000253A patent/CL2010000253A1/es unknown
- 2010-03-24 CA CA2697563A patent/CA2697563C/fr not_active Expired - Fee Related
- 2010-03-24 MX MX2010003213A patent/MX2010003213A/es active IP Right Grant
- 2010-03-25 ZA ZA2010/02120A patent/ZA201002120B/en unknown
- 2010-03-29 TW TW099109448A patent/TWI376371B/zh not_active IP Right Cessation
- 2010-03-29 UA UAA201003585A patent/UA105894C2/uk unknown
- 2010-03-29 AR ARP100101003A patent/AR075978A1/es not_active Application Discontinuation
- 2010-03-29 GE GEAP201011742A patent/GEP20125446B/en unknown
- 2010-03-29 US US12/798,048 patent/US8119794B2/en not_active Expired - Fee Related
- 2010-03-29 NZ NZ584310A patent/NZ584310A/en not_active IP Right Cessation
- 2010-03-29 SA SA110310239A patent/SA110310239B1/ar unknown
- 2010-03-30 BR BRPI1000865-9A patent/BRPI1000865A2/pt not_active Application Discontinuation
- 2010-03-30 EP EP10290165A patent/EP2241553B1/de active Active
- 2010-03-30 EA EA201000398A patent/EA016353B1/ru not_active IP Right Cessation
- 2010-03-30 DK DK10290165.9T patent/DK2241553T3/da active
- 2010-03-30 PL PL10290165T patent/PL2241553T3/pl unknown
- 2010-03-30 SI SI201030007T patent/SI2241553T1/sl unknown
- 2010-03-30 AT AT10290165T patent/ATE517093T1/de active
- 2010-03-30 RS RS20110377A patent/RS51920B/sr unknown
- 2010-03-30 WO PCT/FR2010/000269 patent/WO2010112705A1/fr not_active Ceased
- 2010-03-30 ES ES10290165T patent/ES2370150T3/es active Active
- 2010-03-30 JP JP2010076767A patent/JP5107381B2/ja active Active
- 2010-03-31 CN CN2010101546876A patent/CN101851204B/zh not_active Expired - Fee Related
- 2010-03-31 JO JO2010103A patent/JO2781B1/en active
- 2010-03-31 KR KR1020100029269A patent/KR101166632B1/ko not_active Expired - Fee Related
2011
- 2011-09-22 HR HR20110683T patent/HRP20110683T1/hr unknown
- 2011-10-06 CY CY20111100957T patent/CY1111914T1/el unknown

Also Published As

Publication number	Publication date
AU2010201035B2 (en)	2015-03-19
GEP20125446B (en)	2012-03-26
TWI376371B (en)	2012-11-11
CN101851204A (zh)	2010-10-06
DK2241553T3 (da)	2011-10-31
UY32499A (es)	2010-09-30
JP5107381B2 (ja)	2012-12-26
EP2241553B1 (de)	2011-07-20
US20100249398A1 (en)	2010-09-30
CA2697563A1 (fr)	2010-09-30
UA105894C2 (uk)	2014-07-10
TW201041854A (en)	2010-12-01
MY150014A (en)	2013-11-15
AU2010201035A1 (en)	2010-10-14
US8119794B2 (en)	2012-02-21
EA201000398A1 (ru)	2010-12-30
JO2781B1 (en)	2014-03-15
EA016353B1 (ru)	2012-04-30
CY1111914T1 (el)	2015-11-04
HK1148749A1 (en)	2011-09-16
NZ584310A (en)	2010-11-26
SA110310239B1 (ar)	2014-03-02
ES2370150T3 (es)	2011-12-13
KR20100109527A (ko)	2010-10-08
AR075978A1 (es)	2011-05-11
PE20110098A1 (es)	2011-03-02
FR2943668A1 (fr)	2010-10-01
HRP20110683T1 (hr)	2011-10-31
MA31746B1 (fr)	2010-10-01
JP2010241808A (ja)	2010-10-28
SI2241553T1 (sl)	2011-10-28
MX2010003213A (es)	2010-10-05
ZA201002120B (en)	2010-11-24
BRPI1000865A2 (pt)	2012-01-17
PL2241553T3 (pl)	2011-11-30
FR2943668B1 (fr)	2011-05-06
WO2010112705A1 (fr)	2010-10-07
EP2241553A1 (de)	2010-10-20
CN101851204B (zh)	2013-02-13
CL2010000253A1 (es)	2011-04-25
KR101166632B1 (ko)	2012-07-19
RS51920B (sr)	2012-02-29
CA2697563C (fr)	2012-05-15
ME00986B (me)	2012-06-20

Legal Events

Date

Code

Title

Description

2012-02-15

UEP

Publication of translation of european patent specification

Ref document number: 2241553

Country of ref document: EP

Publication	Publication Date	Title
ATE358123T1 (de)	2007-04-15	Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträgliche säureadditionssalze
EP2433974A4 (de)	2012-08-22	Wässrige polyurethanharzdispersion und verfahren zu ihrer herstellung
EP2402380A4 (de)	2012-08-22	Wässrige polyurethanharzdispersion und verfahren zu ihrer herstellung
EP4183412C0 (de)	2024-08-14	Rsv-f-proteinzusammensetzungen und verfahren zu ihrer herstellung
ATE517093T1 (de)	2011-08-15	Verfahren zur herstellung von ivabradine und deren pharmazeutisch verträglichen säureadditionssalzen
EP2407539A4 (de)	2012-08-15	Multimere sirna und verfahren zu ihrer herstellung
SG2013095930A (en)	2015-07-30	Method for producing lactic acid and method for producing polylactic acid
EP2297779A4 (de)	2012-12-05	Verfahren zur herstellung mehrerer kondensatoren
EP2648261A4 (de)	2016-01-20	Verfahren zur herstellung einer batteriezelle und in diesem verfahren hergestellte batteriezelle
BRPI0817672A2 (pt)	2015-03-31	Método e aparelho para produção de ácido acético com purificação aperfeiçoada
EP2366794A4 (de)	2015-01-21	Verfahren zur herstellung von poly-3-hydroxyalkanoat und poly-3-hydroxyalkanoatagglomerat
EP2333590A4 (de)	2011-09-07	Antireflexionsfolie und verfahren zu ihrer herstellung
EP3797746C0 (de)	2025-05-21	Verbundstoffstruktur und verfahren zu seiner herstellung
EP2297079A4 (de)	2012-08-15	Verfahren zur herstellung von glycolsäure
EP2426780A4 (de)	2015-01-14	Kühlungsverteiler und verfahren zu dessen herstellung
EP2410855A4 (de)	2012-10-17	Verfahren zur herstellung von alogliptin
ATE555098T1 (de)	2012-05-15	Verfahren zur herstellung 1,3-disubstituierter pyrazolcarbonsäureester
EP3821910C0 (de)	2024-12-25	Oligosaccharid und verfahren zur herstellung davon
EP2328546A4 (de)	2015-03-25	Wässriges kosmetikpräparat und verfahren zu dessen herstellung
DE102011050837A8 (de)	2012-08-23	Sensor und Verfahren zur Herstellung desselben
BRPI0905928A2 (pt)	2015-08-04	"método de produção de ácido lático"
DE102009035301A8 (de)	2010-07-22	Verfahren zur Herstellung von Dibenz[c,e][1,2]-oxaphosphorin-Derivaten, Amino-dibenz[c,e][1,2]-oxaphosphorin sowie deren Verwendung
ATE546436T1 (de)	2012-03-15	Verfahren zur herstellung von 2-amino-5- cyanobenzoesäurederivaten
ATE542808T1 (de)	2012-02-15	Verfahren zur herstellung von epichlorydrin aus glyzerin
ATE548345T1 (de)	2012-03-15	Verfahren zur herstellung von agomelatin